Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | AXOGEN, INC. AXGN | Soleus Capital Master Fund, L.P. | 3,005,943 6.800% | 410,128 (+15.80%) | Filing History |
| 2024-11-14 3:30 pm Purchase | 2024-09-30 | 13G | TERNS PHARMACEUTICALS INC TERN | Soleus Capital Master Fund, L.P. | 6,223,544 7.300% | 2,882,424 (+86.27%) | Filing History |
| 2024-11-14 3:30 pm Purchase | 2024-09-30 | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund, L.P. | 6,603,996 9.400% | 4,048,000 (+158.37%) | Filing History |
| 2024-06-07 08:30 am Purchase | 2024-06-06 | 13G | TERNS PHARMACEUTICALS INC TERN | Soleus Capital Master Fund, L.P. | 3,341,120 5.200% | 3,341,120 (New Position) | Filing History |
| 2024-02-09 10:32 am Purchase | 2023-12-31 | 13G | CELCUITY INC CELC | Soleus Capital Master Fund, L.P. | 2,623,890 9.900% | 338,336 (+14.80%) | Filing History |
| 2024-02-08 10:08 am Purchase | 2024-02-05 | 13G | CALCIMEDICA INC CALC | Soleus Capital Master Fund, L.P. | 221,003 9.990% | 64,222 (+40.96%) | Filing History |
| 2024-02-05 10:24 am Purchase | 2024-01-26 | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund, L.P. | 2,555,996 5.200% | 720,000 (+39.22%) | Filing History |
| 2024-02-02 09:59 am Sale | 2023-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Soleus Capital Master Fund, L.P. | 0 0.000% | -50,000 (Position Closed) | Filing History |
| 2024-02-02 09:56 am Purchase | 2023-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund, L.P. | 944,258 5.400% | 21,956 (+2.38%) | Filing History |
| 2024-02-02 09:54 am Purchase | 2023-12-31 | 13G | ORGANOGENESIS HLDGS INC CLASS ORGO | Soleus Capital Master Fund, L.P. | 8,963,000 6.800% | 1,599,937 (+21.73%) | Filing History |
| 2024-02-02 09:53 am Sale | 2023-12-31 | 13G | SURMODICS INC SRDX | Soleus Capital Master Fund, L.P. | 771,700 5.400% | -3,611 (-0.47%) | Filing History |
| 2024-02-02 09:50 am Purchase | 2023-12-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund, L.P. | 987,096 8.800% | 362,096 (+57.94%) | Filing History |
| 2024-02-02 09:49 am Purchase | 2023-12-31 | 13G | VERASTEM INC VSTM | Soleus Capital Master Fund, L.P. | 1,425,634 6.800% | 128,265 (+9.89%) | Filing History |
| 2024-02-02 09:44 am Sale | 2023-12-31 | 13G | IRADIMED CORP COM IRMD | Soleus Capital Master Fund, L.P. | 643,206 5.100% | -101,798 (-13.66%) | Filing History |
| 2024-02-02 09:42 am Sale | 2023-12-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Soleus Capital Master Fund, L.P. | 14,077 5.000% | -3,740 (-20.99%) | Filing History |
| 2024-02-02 09:41 am Purchase | 2023-12-31 | 13G | EDAP TMS S.A. SPONS ADR FOCL | Soleus Capital Master Fund, L.P. | 7,226,341 19.600% | 2,091,911 (+40.74%) | Filing History |
| 2024-02-02 09:37 am Sale | 2023-12-31 | 13G | DELCATH SYS INC DCTH | Soleus Capital Master Fund, L.P. | 0 0.000% | -806,420 (Position Closed) | Filing History |
| 2024-02-02 09:34 am Sale | 2023-12-31 | 13G | C4 THERAPEUTICS INC CCCC | Soleus Capital Master Fund, L.P. | 1,835,996 3.700% | -626,024 (-25.43%) | Filing History |
| 2024-02-02 09:29 am Sale | 2023-12-31 | 13G | AXOGEN, INC. AXGN | Soleus Capital Master Fund, L.P. | 2,595,815 6.000% | -945,483 (-26.70%) | Filing History |
| 2024-01-26 4:15 pm Purchase | 2024-01-23 | 13G | CALCIMEDICA INC CALC | Soleus Capital Master Fund, L.P. | 156,781 7.400% | 156,781 (New Position) | Filing History |